RoB 2: a revised tool for assessing risk of bias in randomised trials
- PMID: 31462531
- DOI: 10.1136/bmj.l4898
RoB 2: a revised tool for assessing risk of bias in randomised trials
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the MRC and Wellcome Trust for the submitted work; JACS reports grants from the MRC and NIHR during the conduct of the study; JS reports grants from the MRC, Cochrane Collaboration, and NIHR during the conduct of the study; CJC is one of the coordinating editors of Cochrane Airways and has responsibility for training Cochrane authors in the UK in Cochrane methodology (including the assessment of risks of bias); JRE reports grants from the MRC and Boehringer Ingelheim, outside the submitted work; MAH reports grants from the National Institutes of Health (NIH) during the conduct of the study; PJ serves as an unpaid member of the steering group of cardiovascular trials funded by Astra Zeneca, Biotronik, Biosensors, St Jude Medical, and The Medicines Company, has received research grants to the institution from Astra Zeneca, Biotronik, Biosensors International, Eli Lilly, and The Medicines Company, and honorariums to the institution for participation in advisory boards from Amgen, but has not received personal payments by any pharmaceutical company or device manufacturer; JJK reports personal fees from BMJ outside the submitted work; TLa is an employee of Cochrane; TLi reports grants from the NIH National Eye Institute, and the Patient-Centered Outcomes Research Institute during the conduct of the study; AM reports grants from MRC and Cancer Research UK during the conduct of the study; KT reports grants from MRC during the conduct of the study and personal fees from CHDI outside the submitted work; JPTH reports grants from the MRC and Cochrane Collaboration during the conduct of the study; the authors declare no other relationships or activities that could appear to have influenced the submitted work.
Comment on
-
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. BMJ. 2011. PMID: 22008217 Free PMC article.
Similar articles
-
Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.BMC Med Res Methodol. 2019 Aug 5;19(1):170. doi: 10.1186/s12874-019-0804-y. BMC Med Res Methodol. 2019. PMID: 31382898 Free PMC article.
-
Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting.Res Synth Methods. 2014 Sep;5(3):200-11. doi: 10.1002/jrsm.1102. Epub 2013 Nov 14. Res Synth Methods. 2014. PMID: 26052846
-
Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.J Clin Epidemiol. 2020 Jul;123:114-119. doi: 10.1016/j.jclinepi.2020.03.019. Epub 2020 Apr 1. J Clin Epidemiol. 2020. PMID: 32247026
-
The risk of bias of animal experiments in implant dentistry: a methodological study.Clin Oral Implants Res. 2017 Jul;28(7):e39-e45. doi: 10.1111/clr.12852. Epub 2016 Apr 16. Clin Oral Implants Res. 2017. PMID: 27083336 Review.
-
The Conduct and Reporting of Child Health Research: An Analysis of Randomized Controlled Trials Published in 2012 and Evaluation of Change over 5 Years.J Pediatr. 2018 Feb;193:237-244.e37. doi: 10.1016/j.jpeds.2017.09.014. Epub 2017 Nov 21. J Pediatr. 2018. PMID: 29169611 Review.
Cited by
-
Bloodletting for Acute Stroke Recovery: A Systematic Review and Meta-Analysis.Healthcare (Basel). 2024 Oct 17;12(20):2060. doi: 10.3390/healthcare12202060. Healthcare (Basel). 2024. PMID: 39451475 Free PMC article. Review.
-
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials.EClinicalMedicine. 2024 Oct 8;76:102835. doi: 10.1016/j.eclinm.2024.102835. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39431112 Free PMC article.
-
Home Biofilm Management in Orthodontic Aligners: A Systematic Review.Dent J (Basel). 2024 Oct 21;12(10):335. doi: 10.3390/dj12100335. Dent J (Basel). 2024. PMID: 39452463 Free PMC article. Review.
-
Effects of Pharmacist-Led Interventions Regarding Adult Patients with Type 2 Diabetes Mellitus in Mexico: A Systematic Review.Pharmacy (Basel). 2024 Sep 27;12(5):148. doi: 10.3390/pharmacy12050148. Pharmacy (Basel). 2024. PMID: 39452804 Free PMC article. Review.
-
A Systematic Review of Gut Microbiota Diversity: A Key Player in the Management and Prevention of Diabetes Mellitus.Cureus. 2024 Sep 18;16(9):e69687. doi: 10.7759/cureus.69687. eCollection 2024 Sep. Cureus. 2024. PMID: 39435211 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
- MC_UU_12023/21/MRC_/Medical Research Council/United Kingdom
- MR/K025635/1/MRC_/Medical Research Council/United Kingdom
- UG1 EY020522/EY/NEI NIH HHS/United States
- MR/L004933/1/MRC_/Medical Research Council/United Kingdom
- MR/J004855/1/MRC_/Medical Research Council/United Kingdom
- G0701659/MRC_/Medical Research Council/United Kingdom
- DRF-2011-04-016/DH_/Department of Health/United Kingdom
- MC_UU_00011/3/MRC_/Medical Research Council/United Kingdom
- MR/M025209/1/MRC_/Medical Research Council/United Kingdom
- MR/S001751/1/MRC_/Medical Research Council/United Kingdom
- MR/K025643/1/MRC_/Medical Research Council/United Kingdom
- MR/L004933/2/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources